Effect of Alpha-Latrotoxin on the Frog Neuromuscular Junction at Low

Total Page:16

File Type:pdf, Size:1020Kb

Effect of Alpha-Latrotoxin on the Frog Neuromuscular Junction at Low Journal of Physiology (1988), 402, pp. 195-217 195 With 4 plate8 and 5 text-figures Printed in Great Britain EFFECT OF ae-LATROTOXIN ON THE FROG NEUROMUSCULAR JUNCTION AT LOW TEMPERATURE BY B. CECCARELLI, W. P. HURLBUT* AND N. IEZZI From the Department of Medical Pharmacology, CNR Center of Cytopharmacology and Center for the Study of Peripheral Neuropathies and Neuromuscular Diseases, Via Vanvitelli 32, 20129 Milano, Italy, and the Rockefeller University*, 1230 York Avenue, New York, NY 10021, U.S.A. (Received 13 July 1987) SUMMARY 1. a-Latrotoxin (a-LTx) was applied to frog cutaneus pectoris muscles bathed at 1-3 °C in either Ringer solution, Ca2"-free Ringer solution with 1 mM-EGTA and 4 mM-Mg2+ or Ringer solution plus 4 mM-Mg2+, and its effects on miniature end-plate potential (MEPP) frequency, nerve terminal ultrastructure and uptake of horse- radish peroxidase (HRP) were studied. 2. Large concentrations (2 ,ug/ml) of a-LTx increased MEPP rates to levels above 100/s at all junctions, but the time course of the increases depended upon the divalent cation content of the bathing solution. However, similar numbers ofMEPPs (0-3-407 x 106) were recorded at all junctions during 2 h of secretion. 3. Nerve terminals exposed to a-LTx for 2 h lost 60-75 % oftheir synaptic vesicles and were swollen; their presynaptic membranes were deeply infolded and they often contained many large vesicular structures. Terminals in Ringer solution retained the largest number of synaptic vesicles; terminals in Ringer solution plus Mg2+ swelled the least and contained the largest number of coated vesicles. The average number of synaptic vesicles lost was approximately equal to the average number of MEPPs recorded. 4. Few vesicles became loaded with HRP when this extracellular tracer was present in the bathing solution and the muscles were fixed near the peak of secretion. 5. When the terminals were warmed to 20 °C, those in the Caa2+-free solution with Mg2+ secreted additional quanta and lost almost all their residual vesicles; those in Ringer solution without Mg2+ secreted few additional quanta and retained most of their residual vesicles. 6. These results suggest that recycling was blocked at these terminals and that for each quantum secreted a vesicle became permanently incorporated into the axolemma. INTRODUCTION The acetylcholine (ACh) in vertebrate motor nerve terminals is stored in two major compartments: the axoplasm and the synaptic vesicles (Whittaker, Michaelson & Kirkland, 1964; Dunant, Gautron, Israel, Lesbats & Manaranche, 1972). ACh is 7-2 196 B. CECCARELLI, W. P. HURLBUT AND N. IEZZI released from a terminal both in a steady 'leak' (Katz & Miledi, 1977; Vyscocil & Illes, 1979; Edwards, Dolezal, Tucek, Zemkova & Vyskocil, 1985), and in a pulsatile manner as multimolecular packets, or quanta (del Castillo & Katz, 1954). The total release, i.e. the sum of the 'leak' and the quantal components, is measurable by biochemical means (Gorio, Hurlbut & Ceccarelli, 1978; Israel & Lesbats, 1981). The 'leak', or non-quantal component of release, is difficult to measure directly since its major known effect is to produce a small, steady depolarization at an end-plate when acetylcholinesterase has been thoroughly inhibited. Therefore, neither its function or origin within the terminal are known (Edwards et al. 1985). Quantal release, on the other hand, is easily detected by electrophysiological means, and its function is well known since it generates the transient end-plate potentials (EPPs) and miniature end-plate potentials (MEPPs) that mediate neuromuscular transmission (Fatt & Katz, 1952; del Castillo & Katz, 1954; Boyd & Martin, 1956). Although recent quick-freeze studies of frog terminals treated with 4-amino- pyridine have demonstrated that vesicles fuse with the presynaptic membrane a few milliseconds after the arrival of a single nerve impulse (Heuser, Reese, Dennis, Jan, Jan & Evans, 1979; Torri-Tarelli, Grohovaz, Fesce & Ceccarelli, 1985), controversy still exists over whether the secreted quanta represent ACh that is released from the interiors of the fused vesicles (Tauc, 1982). An alternative hypothesis is that the quanta represent axoplasmic ACh which diffuses in pulses through channels in the presynaptic membrane that become transiently permeable to it (Tauc, 1982; Israel & Manaranche, 1985). If quanta were released by exocytosis from the interiors of vesicles which have fused with the presynaptic membrane, then one might expect a vesicle to be lost whenever a quantum is secreted. However, most terminals can secrete large numbers of quanta before they lose significant numbers of vesicles (reviewed by Ceccarelli & Hurlbut, 1980a). On the other hand, vesicles are formed from the axolemma of rapidly secreting terminals, and it has been suggested that these newly formed vesicles are recycled vermions of the original ones and can reaccumulate and secrete additional quanta of ACh (Ceccarelli & Hurlbut, 1980a). Thus, the number of vesicles lost should equal the number of quanta secreted only when endocytosis and vesicle recycling are blocked. Endocytosis is inhibited at terminals treated with ouabain, or with black widow spider venom in Ca2+-free Ringer solution, and such terminals secrete spontaneously until they are exhausted of quanta and depleted of vesicles (Clark, Hurlbut & Mauro, 1972; Ceccarelli & Hurlbut, 1980b; Haimann, Torri-Tarelli, Fesce & Ceccarelli, 1985). The total number of MEPPs that occur at such terminals is similar to the number of synaptic vesicles in resting terminals (- 7 x 105) (Haiman et al. 1985; Fesce, Segal, Ceccarelli & Hurlbut, 1986b), but additional comparisons of MEPP counts and vesicle counts need to be made under other conditions which inhibit endocytosis and stimulate quantal secretion. Since low temperature appears to be an effective inhibitor of most endocytotic processes in mammalian cells (Steinman, Mellman, Muller & Cohn, 1983), we have studied the effects of a-latrotoxin (a-LTx), a purified protein component of black widow spider venom (Frontali, Ceccarelli, Gorio, Mauro, Siekevitz, Tzeng & Hurlbut, 1976), on quantal secretion, nerve terminal ultrastructure and uptake of horseradish peroxidase (HRP) at frog neuromuscular junctions at 1-3 'C. We were especially interested in these ac-LATROTOXIN AT LOW TEMPERATURE 197 experiments because Heuser & Miledi (1971) had previously estimated that several million quanta were secreted from terminals treated with La3+ at 4 'C. Evoked and spontaneous quantal release are highly temperature dependent, and the quantal content of the EPP and the rate of occurrence of MEPPs decline to low values at temperatures below 10 'C (see Barrett, Barrett, Botz, Chang & Mahaffey, 1978, for references). Previous studies of the effect of temperature on the action of black widow spider venom or a-LTx showed that binding occurs at temperatures near 0 'C (Valtorta, Madeddu, Meldolesi & Ceccarelli, 1984), but quantal release is small when moderate doses of these agents were used (Rubin, 1976; Pumplin & Reese, 1977; Fritz, 1980). However, we have found that high concentrations of o- LTx (2 ,ug/ml) raise MEPP rates to several hundred per second at temperatures of 1-3 'C and cause a profound depletion of vesicles after 2 h. METHODS General. Cutaneus pectoris muscles were dissected from frogs (Rana pipien8) together with a short length of nerve, a small flap of skin that covered the throat and a short length of rectus abdominis muscle. The preparation was stretched over a lucite lens on the floor of a thin-bottomed lucite recording chamber and pinned into pads of dental wax at each end. The chamber held about 3 ml of bathing solution and could be perfused. The standard bathing solution (Ringer solution) contained (in mM): NaCl, 116; KCl, 2-1; CaCl2, 1-8; phosphate buffer, 3-0; at pH 7-0. The Ca21- free Ringer solution contained no added CaCl2, 1 mm-ethyleneglycol-bis-(,8-aminoethylether)N,N'- tetraacetic acid (EGTA) and 4 mM-MgCl2; the Ringer solution with Mg2+ contained 4 mM-MgCl2 in addition to the other salts. The concentration of NaCl in the modified Ringer solutions was adjusted to keep the tonicity constant. Tetrodotoxin (TTX, 10-7-10-8 g/ml) was added to all solutions to prevent the muscle fibres from twitching. The recording chamber was mounted on a Peltier device and cooled to a temperature of 1-3 'C as measured by a thermistor pressed firmly against the wax pad near the edge of the muscle. Electrophysiology. End-plate regions were impaled by glass micropipettes filled with 3 M-KCI (resistances 10-30 MQ at room temperature), and MEPPs were recorded with a conventional high- input-impedance amplifier and stored on FM magnetic tape (tape speed: 4-75 cm/s, bandwidth 0-600 Hz for experiments at 1-3 'C; speed 9-5 cm/s, bandwidth 0-1250 Hz at room temperature) for later analysis by computer (Digital Equipment Corp., PDP 11/73). One channel of the tape- recorder stored a high-gain AC-coupled record (bandwidth 0-03-600 Hz at 1-3 'C, or 0-15-1250 Hz at room temperature) of the deviations of the membrane potential from its mean, and a second channel stored a low-gain DC record of the absolute value of the membrane potential. A baseline record 3-5 min in duration was collected, then a-LTx was applied and the potentials were recorded continuously for 45-60 min; they were recorded intermittently at later times. In each experiment we used a different muscle and tried to record from a single neuromuscular junction throughout its discharge of quanta. Data were collected at a particular junction as long as the MEPP rate exceeded - 20/s and the individual MEPPs could be distinguished from noise. We were successful in sixteen experiments at low temperature. In two additional experiments reported here the initial impalements were lost after about an hour (i.e. well after the time the rate of secretion had passed through its peak); in these two cases a second junction was impaled and its quantal secretion added to that of the first junction.
Recommended publications
  • Download Product Insert (PDF)
    PRODUCT INFORMATION α-Bungarotoxin (trifluoroacetate salt) Item No. 16385 Synonyms: α-Bgt, α-BTX Peptide Sequence: IVCHTTATSPISAVTCPPGENLCY Ile Val Cys His Thr Thr Ala Thr Ser Pro RKMWCDAFCSSRGKVVELGCAA Ile Ser Ala Val Thr Cys Pro Pro Gly Glu TCPSKKPYEEVTCCSTDKCNPHP KQRPG, trifluoroacetate salt Asn Leu Cys Tyr Arg Lys Met Trp Cys Asp (Modifications: Disulfide bridge between Ala Phe Cys Ser Ser Arg Gly Lys Val Val 3-23, 16-44, 29-33, 48-59, 60-65) Glu Leu Gly Cys Ala Ala Thr Cys Pro Ser MF: C338H529N97O105S11 • XCF3COOH FW: 7,984.2 Lys Lys Pro Tyr Glu Glu Val Thr Cys Cys Supplied as: A solid Ser Thr Asp Lys Cys Asn Pro His Pro Lys Storage: -20°C Gln Arg Pro Gly Stability: ≥2 years • XCF COOH Solubility: Soluble in aqueous buffers 3 Information represents the product specifications. Batch specific analytical results are provided on each certificate of analysis. Laboratory Procedures α-Bungarotoxin (trifluoroacetate salt) is supplied as a solid. A stock solution may be made by dissolving the α-bungarotoxin (trifluoroacetate salt) in water. The solubility of α-bungarotoxin (trifluoroacetate salt) in water is approximately 1 mg/ml. We do not recommend storing the aqueous solution for more than one day. Description α-Bungarotoxin is a snake venom-derived toxin that irreversibly binds nicotinic acetylcholine receptors (Ki = ~2.5 µM in rat) present in skeletal muscle, blocking action of acetylcholine at the postsynaptic membrane and leading to paralysis.1-3 It has been widely used to characterize activity at the neuromuscular junction, which has numerous applications in neuroscience research.4,5 References 1.
    [Show full text]
  • Nervous Tissue
    Nervous Tissue Prof.Prof. ZhouZhou LiLi Dept.Dept. ofof HistologyHistology andand EmbryologyEmbryology Organization:Organization: neuronsneurons (nerve(nerve cells)cells) neuroglialneuroglial cellscells Function:Function: Ⅰ Neurons 1.1. structurestructure ofof neuronneuron somasoma neuriteneurite a.a. dendritedendrite b.b. axonaxon 1.11.1 somasoma (1)(1) nucleusnucleus LocatedLocated inin thethe centercenter ofof soma,soma, largelarge andand palepale--stainingstaining nucleusnucleus ProminentProminent nucleolusnucleolus (2)(2) cytoplasmcytoplasm (perikaryon)(perikaryon) a.a. NisslNissl bodybody b.b. neurofibrilneurofibril NisslNissl’’ss bodiesbodies LM:LM: basophilicbasophilic massmass oror granulesgranules Nissl’s Body (TEM) EMEM:: RERRER,, freefree RbRb FunctionFunction:: producingproducing thethe proteinprotein ofof neuronneuron structurestructure andand enzymeenzyme producingproducing thethe neurotransmitterneurotransmitter NeurofibrilNeurofibril thethe structurestructure LM:LM: EM:EM: NeurofilamentNeurofilament micmicrotubulerotubule FunctionFunction cytoskeleton,cytoskeleton, toto participateparticipate inin substancesubstance transporttransport LipofuscinLipofuscin (3)(3) CellCell membranemembrane excitableexcitable membranemembrane ,, receivingreceiving stimutation,stimutation, fromingfroming andand conductingconducting nervenerve impulesimpules neurite: 1.2 Dendrite dendritic spine spine apparatus Function: 1.3 Axon axon hillock, axon terminal, axolemma Axoplasm: microfilament, microtubules, neurofilament, mitochondria,
    [Show full text]
  • Recent Advances in Research on Widow Spider Venoms and Toxins
    Review Recent Advances in Research on Widow Spider Venoms and Toxins Shuai Yan and Xianchun Wang * Received: 2 August 2015; Accepted: 16 November 2015; Published: 27 November 2015 Academic Editors: Richard J. Lewis and Glenn F. King Key Laboratory of Protein Chemistry and Developmental Biology of Ministry of Education, College of Life Sciences, Hunan Normal University, Changsha 410081, China; [email protected] * Correspondence: [email protected]; Tel.: +86-731-8887-2556 Abstract: Widow spiders have received much attention due to the frequently reported human and animal injures caused by them. Elucidation of the molecular composition and action mechanism of the venoms and toxins has vast implications in the treatment of latrodectism and in the neurobiology and pharmaceutical research. In recent years, the studies of the widow spider venoms and the venom toxins, particularly the α-latrotoxin, have achieved many new advances; however, the mechanism of action of the venom toxins has not been completely clear. The widow spider is different from many other venomous animals in that it has toxic components not only in the venom glands but also in other parts of the adult spider body, newborn spiderlings, and even the eggs. More recently, the molecular basis for the toxicity outside the venom glands has been systematically investigated, with four proteinaceous toxic components being purified and preliminarily characterized, which has expanded our understanding of the widow spider toxins. This review presents a glance at the recent advances in the study on the venoms and toxins from the Latrodectus species. Keywords: widow spider; venom; toxin; latrotoxin; latroeggtoxin; advance 1. Introduction Latrodectus spp.
    [Show full text]
  • Pre-Oligodendrocytes from Adult Human CNS
    The Journal of Neuroscience, April 1992, 12(4): 1538-l 547 Pre-Oligodendrocytes from Adult Human CNS Regina C. Armstrong,lJ Henry H. Dorn, l,b Conrad V. Kufta,* Emily Friedman,3 and Monique E. Dubois-Dalcq’ ‘Laboratory of Viral and Molecular Pathogenesis, and %urgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland 20892 and 3Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania 19104-3246 CNS remyelination and functional recovery often occur after Rapid and efficient neurotransmission is dependent upon the experimental demyelination in adult rodents. This has been electrical insulating capacity of the myelin sheath around axons attributed to the ability of mature oligodendrocytes and/or (reviewed in Ritchie, 1984a,b). Nerve conduction is impaired their precursor cells to divide and regenerate in response after loss of the myelin sheath and results in severe neurological to signals in demyelinating lesions. To determine whether dysfunction in human demyelinating diseases such as multiple oligodendrocyte precursor cells exist in the adult human sclerosis (MS). Remyelination can occur in the CNS of MS CNS, we have cultured white matter from patients under- patients but appears to be limited (Perier and Gregoire, 1965; going partial temporal lobe resection for intractable epilep- Prineas et al., 1984). Studies of acute MS cases have revealed sy. These cultures contained a population of process-bear- that recent demyelinating lesions can exhibit remyelination that ing cells that expressed antigens recognized by the 04 appears to correlate with the generation of new oligodendrocytes monoclonal antibody, but these cells did not express galac- (Prineas et al., 1984; Raine et al., 1988).
    [Show full text]
  • Acute Reduction of Microglia Does Not Alter Axonal Injury in a Mouse Model of Repetitive Concussive Traumatic Brain Injury Rachel E
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 Acute reduction of microglia does not alter axonal injury in a mouse model of repetitive concussive traumatic brain injury Rachel E. Bennett Washington University School of Medicine David L. Brody Washington University School of Medicine Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Bennett, Rachel E. and Brody, David L., ,"Acute reduction of microglia does not alter axonal injury in a mouse model of repetitive concussive traumatic brain injury." Journal of Neurotrauma.31,9. 1647-1663. (2014). https://digitalcommons.wustl.edu/open_access_pubs/4711 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. JOURNAL OF NEUROTRAUMA 31:1647–1663 (October 1, 2014) ª Mary Ann Liebert, Inc. DOI: 10.1089/neu.2013.3320 Acute Reduction of Microglia Does Not Alter Axonal Injury in a Mouse Model of Repetitive Concussive Traumatic Brain Injury Rachel E. Bennett and David L. Brody Abstract The pathological processes that lead to long-term consequences of multiple concussions are unclear. Primary mechanical damage to axons during concussion is likely to contribute to dysfunction. Secondary damage has been hypothesized to be induced or exacerbated by inflammation. The main inflammatory cells in the brain are microglia, a type of macrophage. This research sought to determine the contribution of microglia to axon degeneration after repetitive closed-skull traumatic brain injury (rcTBI) using CD11b-TK (thymidine kinase) mice, a valganciclovir-inducible model of macrophage depletion.
    [Show full text]
  • Α-Neurexins Together Withα2δ-1 Auxiliary Subunits Regulate Ca
    The Journal of Neuroscience, September 19, 2018 • 38(38):8277–8294 • 8277 Cellular/Molecular ␣-Neurexins Together with ␣2␦-1 Auxiliary Subunits 2ϩ Regulate Ca Influx through Cav2.1 Channels X Johannes Brockhaus,1* Miriam Schreitmu¨ller,1* Daniele Repetto,1 Oliver Klatt,1,2 XCarsten Reissner,1 X Keith Elmslie,3 Martin Heine,2 and XMarkus Missler1,4 1Institute of Anatomy and Molecular Neurobiology, Westfa¨lische Wilhelms-University, 48149 Mu¨nster, Germany, 2Molecular Physiology Group, Leibniz- Institute of Neurobiology, 39118 Magdeburg, Germany, 3Department of Pharmacology, AT Still University of Health Sciences, Kirksville, Missouri 63501, and 4Cluster of Excellence EXC 1003, Cells in Motion, 48149 Mu¨nster, Germany Action potential-evoked neurotransmitter release is impaired in knock-out neurons lacking synaptic cell-adhesion molecules ␣-neurexins (␣Nrxns), the extracellularly longer variants of the three vertebrate Nrxn genes. Ca 2ϩ influx through presynaptic high- ␣ ␦ voltage gated calcium channels like the ubiquitous P/Q-type (CaV2.1) triggers release of fusion-ready vesicles at many boutons. 2 Auxiliary subunits regulate trafficking and kinetic properties of CaV2.1 pore-forming subunits but it has remained unclear if this involves ␣Nrxns. Using live cell imaging with Ca 2ϩ indicators, we report here that the total presynaptic Ca 2ϩ influx in primary hippocampal ␣ neurons of Nrxn triple knock-out mice of both sexes is reduced and involved lower CaV2.1-mediated transients. This defect is accom- ␣ ␦ panied by lower vesicle release, reduced synaptic abundance of CaV2.1 pore-forming subunits, and elevated surface mobility of 2 -1 on axons. Overexpression of Nrxn1␣ in ␣Nrxn triple knock-out neurons is sufficient to restore normal presynaptic Ca 2ϩ influx and synaptic vesicle release.
    [Show full text]
  • Lllostridium Botulinum Neurotoxinl I H
    MICROBIOLOGICAL REVIEWS, Sept. 1980, p. 419-448 Vol. 44, No. 3 0146-0749/80/03-0419/30$0!)V/0 Lllostridium botulinum Neurotoxinl I H. WJGIYAMA Food Research Institute and Department ofBacteriology, University of Wisconsin, Madison, Wisconsin 53706 INTRODUCTION ........ .. 419 PATHOGENIC FORMS OF BOTULISM ........................................ 420 Food Poisoning ............................................ 420 Wound Botulism ............................................ 420 Infant Botulism ............................................ 420 CULTURES AND TOXIN TYPES ............................................ 422 Culture-Toxin Relationships ............................................ 422 Culture Groups ............................................ 422 GENETICS OF TOXIN PRODUCTION ......................................... 423 ASSAY OF TOXIN ............................................ 423 In Vivo Quantitation ............................................ 424 Infant-Potent Toxin ............................................ 424 Serological Assays ............................................ 424 TOXIC COMPLEXES ............................................ 425 Complexes 425 Structure of Complexes ...................................................... 425 Antigenicity and Reconstitution .......................... 426 Significance of Complexes .......................... 426 Nomenclature ........................ 427 NEUROTOXIN ..... 427 Molecular Weight ................... 427 Specific Toxicity ................... 428 Small Toxin ..................
    [Show full text]
  • Was Not Reached, However, Even After Six to Sevenhours. A
    PROTEIN SYNTHESIS IN THE ISOLATED GIANT AXON OF THE SQUID* BY A. GIUDITTA,t W.-D. DETTBARN,t AND MIROSLAv BRZIN§ MARINE BIOLOGICAL LABORATORY, WOODS HOLE, MASSACHUSETTS Communicated by David Nachmansohn, February 2, 1968 The work of Weiss and his associates,1-3 and more recently of a number of other investigators,4- has established the occurrence of a flux of materials from the soma of neurons toward the peripheral regions of the axon. It has been postulated that this mechanism would account for the origin of most of the axonal protein, although the time required to cover the distance which separates some axonal tips from their cell bodies would impose severe delays.4 On the other hand, a number of observations7-9 have indicated the occurrence of local mechanisms of synthesis in peripheral axons, as suggested by the kinetics of appearance of individual proteins after axonal transection. In this paper we report the incorporation of radioactive amino acids into the protein fraction of the axoplasm and of the axonal envelope obtained from giant axons of the squid. These axons are isolated essentially free from small fibers and connective tissue, and pure samples of axoplasm may be obtained by extru- sion of the axon. Incorporation of amino acids into axonal protein has recently been reported using systems from mammals'0 and fish."I Materials and Methods.-Giant axons of Loligo pealii were dissected and freed from small fibers: they were tied at both ends. Incubations were carried out at 18-20° in sea water previously filtered through Millipore which contained 5 mM Tris pH 7.8 and 10 Muc/ml of a mixture of 15 C'4-labeled amino acids (New England Nuclear Co., Boston, Mass.).
    [Show full text]
  • Mitochondrial Alarmins Released by Degenerating Motor Axon Terminals
    Mitochondrial alarmins released by degenerating PNAS PLUS motor axon terminals activate perisynaptic Schwann cells Elisa Duregottia, Samuele Negroa, Michele Scorzetoa, Irene Zornettaa, Bryan C. Dickinsonb,c,1, Christopher J. Changb,c, Cesare Montecuccoa,d,2, and Michela Rigonia,2 aDepartment of Biomedical Sciences, University of Padua, Padua 35131, Italy; bDepartment of Chemistry and Molecular and Cell Biology and cHoward Hughes Medical Institute, University of California, Berkeley, CA 94720; and dItalian National Research Council Institute of Neuroscience, Padua 35131, Italy Edited by Thomas C. Südhof, Stanford University School of Medicine, Stanford, CA, and approved December 22, 2014 (received for review September 5, 2014) An acute and highly reproducible motor axon terminal degeneration of nerve terminal degeneration (21). Indeed, these neurotoxins followed by complete regeneration is induced by some animal cause activation of the calcium-activated calpains that contribute to presynaptic neurotoxins, representing an appropriate and controlled cytoskeleton fragmentation (22). system to dissect the molecular mechanisms underlying degeneration Although clearly documented (4, 5, 20), the regeneration of and regeneration of peripheral nerve terminals. We have previously the motor axon terminals after presynaptic neurotoxins injection shown that nerve terminals exposed to spider or snake presynaptic is poorly known in its cellular and molecular aspects. Available neurotoxins degenerate as a result of calcium overload and mito- evidence indicates that, in general, regeneration of mechan- chondrial failure. Here we show that toxin-treated primary neurons ically damaged motor neuron terminals relies on all three cel- release signaling molecules derived from mitochondria: hydrogen lular components of the neuromuscular junction (NMJ): the peroxide, mitochondrial DNA, and cytochrome c.
    [Show full text]
  • (Caspr) and Contactin Form a Complex That Is Targeted to the Paranodal Junctions During Myelination
    The Journal of Neuroscience, November 15, 2000, 20(22):8354–8364 Contactin-Associated Protein (Caspr) and Contactin Form a Complex That Is Targeted to the Paranodal Junctions during Myelination Jose C. Rios,1 Carmen V. Melendez-Vasquez,1 Steven Einheber,1 Marc Lustig,2 Martin Grumet,2 John Hemperly,5 Elior Peles,6 and James L. Salzer1,3,4 Departments of 1Cell Biology, 2Pharmacology, 3Neurology, and the 4Kaplan Cancer Center, New York University School of Medicine, New York, New York 10016, 5BD Technologies, Research Triangle Park, North Carolina 27709, and 6Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel Specialized paranodal junctions form between the axon and the associated specifically with Caspr in the paranodes, whereas a closely apposed paranodal loops of myelinating glia. They are higher-molecular-weight form of contactin, not associated with interposed between sodium channels at the nodes of Ranvier Caspr, is present in central nodes of Ranvier. These results and potassium channels in the juxtaparanodal regions; their suggest that the targeting of contactin to different axonal do- precise function and molecular composition have been elusive. mains may be determined, in part, via its association with Caspr. We previously reported that Caspr (contactin-associated protein) Treatment of myelinating cocultures of Schwann cells and neu- is a major axonal constituent of these junctions (Einheber et al., rons with RPTP␤–Fc, a soluble construct containing the carbonic 1997). We now report that contactin colocalizes and forms a cis anhydrase domain of the receptor protein tyrosine phosphatase complex with Caspr in the paranodes and juxtamesaxon.
    [Show full text]
  • Rope Parasite” the Rope Parasite Parasites: Nearly Every AuSC Child I Ever Treated Proved to Carry a Significant Parasite Burden
    Au#sm: 2015 Dietrich Klinghardt MD, PhD Infec4ons and Infestaons Chronic Infecons, Infesta#ons and ASD Infec4ons affect us in 3 ways: 1. Immune reac,on against the microbes or their metabolic products Treatment: low dose immunotherapy (LDI, LDA, EPD) 2. Effects of their secreted endo- and exotoxins and metabolic waste Treatment: colon hydrotherapy, sauna, intes4nal binders (Enterosgel, MicroSilica, chlorella, zeolite), detoxificaon with herbs and medical drugs, ac4vaon of detox pathways by solving underlying blocKages (methylaon, etc.) 3. Compe,,on for our micronutrients Treatment: decrease microbial load, consider vitamin/mineral protocol Lyme, Toxins and Epigene#cs • In 2000 I examined 10 au4s4c children with no Known history of Lyme disease (age 3-10), with the IgeneX Western Blot test – aer successful treatment. 5 children were IgM posi4ve, 3 children IgG, 2 children were negave. That is 80% of the children had clinical Lyme disease, none the history of a 4cK bite! • Why is it taking so long for au4sm-literate prac44oners to embrace the fact, that many au4s4c children have contracted Lyme or several co-infec4ons in the womb from an oVen asymptomac mother? Why not become Lyme literate also? • Infec4ons can be treated without the use of an4bio4cs, using liposomal ozonated essen4al oils, herbs, ozone, Rife devices, PEMF, colloidal silver, regular s.c injecons of artesunate, the Klinghardt co-infec4on cocKtail and more. • Symptomac infec4ons and infestaons are almost always the result of a high body burden of glyphosate, mercury and aluminum - against the bacKdrop of epigene4c injuries (epimutaons) suffered in the womb or from our ancestors( trauma, vaccine adjuvants, worK place related lead, aluminum, herbicides etc., electromagne4c radiaon exposures etc.) • Most symptoms are caused by a confused upregulated immune system (molecular mimicry) Toxins from a toxic environment enter our system through damaged boundaries and membranes (gut barrier, blood brain barrier, damaged endothelium, etc.).
    [Show full text]
  • Α-LATROTOXIN and ITS RECEPTORS: Neurexins
    P1: FQP April 4, 2001 18:17 Annual Reviews AR121-30 Annu. Rev. Neurosci. 2001. 24:933–62 Copyright c 2001 by Annual Reviews. All rights reserved -LATROTOXIN AND ITS RECEPTORS: Neurexins and CIRL/Latrophilins ThomasCSudhof¨ Howard Hughes Medical Institute, Center for Basic Neuroscience, and the Department of Molecular Genetics, The University of Texas Southwestern Medical Center at Dallas, Texas 75390-9111, e-mail: [email protected] Key Words neurotransmitter release, synaptic vesicles, exocytosis, membrane fusion, synaptic cell adhesion ■ Abstract -Latrotoxin, a potent neurotoxin from black widow spider venom, triggers synaptic vesicle exocytosis from presynaptic nerve terminals. -Latrotoxin is a large protein toxin (120 kDa) that contains 22 ankyrin repeats. In stimulating exocytosis, -latrotoxin binds to two distinct families of neuronal cell-surface receptors, neurexins and CLs (Cirl/latrophilins), which probably have a physiological function in synaptic cell adhesion. Binding of -latrotoxin to these receptors does not in itself trigger exocytosis but serves to recruit the toxin to the synapse. Receptor-bound -latrotoxin then inserts into the presynaptic plasma membrane to stimulate exocytosis by two dis- tinct transmitter-specific mechanisms. Exocytosis of classical neurotransmitters (glu- tamate, GABA, acetylcholine) is induced in a calcium-independent manner by a direct intracellular action of -latrotoxin, while exocytosis of catecholamines requires extra- cellular calcium. Elucidation of precisely how -latrotoxin works is likely to provide major insight into how synaptic vesicle exocytosis is regulated, and how the release machineries of classical and catecholaminergic neurotransmitters differ. by SCELC Trial on 09/09/11. For personal use only. INTRODUCTION Annu. Rev. Neurosci. 2001.24:933-962.
    [Show full text]